Viatris ROA 2010-2024 | VTRS

Current and historical return on assets (ROA) values for Viatris (VTRS) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Viatris ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-12-31 $-0.63B $41.50B -1.42%
2024-09-30 $-0.88B $44.75B -1.91%
2024-06-30 $-0.65B $45.33B -1.37%
2024-03-31 $-0.06B $47.34B -0.12%
2023-12-31 $0.05B $47.69B 0.11%
2023-09-30 $1.83B $48.74B 3.72%
2023-06-30 $1.85B $48.70B 3.77%
2023-03-31 $1.90B $49.29B 3.83%
2022-12-31 $2.08B $50.02B 4.09%
2022-09-30 $0.80B $48.66B 1.54%
2022-06-30 $0.76B $51.13B 1.41%
2022-03-31 $0.17B $53.47B 0.30%
2021-12-31 $-1.27B $54.84B -2.23%
2021-09-30 $-1.92B $56.07B -3.28%
2021-06-30 $-2.05B $57.98B -3.90%
2021-03-31 $-1.73B $58.98B -3.80%
2020-12-31 $-0.67B $61.55B -1.75%
2020-09-30 $0.27B $31.24B 0.87%
2020-06-30 $0.27B $30.16B 0.88%
2020-03-31 $0.06B $30.15B 0.20%
2019-12-31 $0.02B $31.26B 0.05%
2019-09-30 $0.05B $31.05B 0.15%
2019-06-30 $0.03B $31.82B 0.10%
2019-03-31 $0.24B $31.91B 0.73%
2018-12-31 $0.35B $32.74B 1.05%
2018-09-30 $0.55B $33.46B 1.59%
2018-06-30 $0.46B $33.27B 1.30%
2018-03-31 $0.72B $35.19B 2.01%
2017-12-31 $0.70B $35.81B 1.97%
2017-09-30 $0.87B $35.82B 2.48%
2017-06-30 $0.66B $35.51B 1.87%
2017-03-31 $0.53B $34.27B 1.58%
2016-12-31 $0.48B $34.73B 1.56%
2016-09-30 $0.26B $36.54B 0.93%
2016-06-30 $0.81B $28.84B 3.39%
2016-03-31 $0.81B $22.64B 3.62%
2015-12-31 $0.85B $22.27B 3.84%
2015-09-30 $0.84B $21.32B 4.11%
2015-06-30 $0.91B $22.80B 4.81%
2015-03-31 $0.87B $22.12B 5.06%
2014-12-31 $0.93B $15.82B 6.00%
2014-09-30 $0.92B $15.17B 5.99%
2014-06-30 $0.58B $15.60B 3.92%
2014-03-31 $0.63B $15.36B 4.54%
2013-12-31 $0.62B $15.30B 4.77%
2013-09-30 $0.61B $12.90B 4.95%
2013-06-30 $0.66B $12.21B 5.51%
2013-03-31 $0.62B $11.89B 5.25%
2012-12-31 $0.64B $11.93B 5.44%
2012-09-30 $0.61B $11.71B 5.19%
2012-06-30 $0.55B $11.60B 4.79%
2012-03-31 $0.56B $11.93B 4.81%
2011-12-31 $0.54B $11.60B 4.60%
2011-09-30 $0.41B $11.12B 3.52%
2011-06-30 $0.36B $12.01B 3.08%
2011-03-31 $0.27B $11.88B 2.34%
2010-12-31 $0.22B $11.54B 2.01%
2010-09-30 $0.22B $11.41B 2.05%
2010-06-30 $0.08B $10.60B 0.71%
2010-03-31 $0.08B $10.82B 0.78%
2009-12-31 $0.09B $10.80B 0.89%
Sector Industry Market Cap Revenue
Medical Medical Services $10.317B $14.739B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $140.708B 26.39
Elevance Health (ELV) United States $84.816B 10.94
CVS Health (CVS) United States $76.534B 9.51
Cencora (COR) United States $54.103B 18.81
DiDi Global (DIDIY) China $21.367B 32.43
Natera (NTRA) United States $20.793B 0.00
BioMerieux (BMXMF) France $15.263B 0.00
Solventum (SOLV) United States $12.720B 13.47
EUROFINS SCIENT (ERFSF) Luxembourg $11.739B 0.00
Revvity (RVTY) United States $11.399B 19.62
CochLear (CHEOY) Australia $11.361B 0.00
ICON (ICLR) Ireland $11.346B 10.55
Doximity (DOCS) United States $11.282B 58.67
Avantor (AVTR) United States $9.063B 13.17
Medpace Holdings (MEDP) United States $8.914B 23.68
HealthEquity (HQY) United States $8.389B 41.27
Sonic Healthcare (SKHHY) Australia $8.349B 0.00
Charles River Laboratories (CRL) United States $7.074B 13.86
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
Bausch + Lomb (BLCO) Canada $4.156B 24.50
BrightSpring Health Services (BTSG) United States $4.049B 37.48
Sotera Health (SHC) United States $3.758B 21.35
Surgery Partners (SGRY) United States $2.939B 38.22
Alignment Healthcare (ALHC) United States $2.780B 0.00
Concentras Parent (CON) United States $2.743B 15.85
Organon (OGN) United States $2.194B 2.33
Premier (PINC) United States $2.087B 14.29
Ardent Health Partners (ARDT) United States $2.077B 8.85
Progyny (PGNY) United States $1.858B 40.91
GeneDx Holdings (WGS) United States $1.739B 66.96
PACS (PACS) United States $1.669B 0.00
GoodRx Holdings (GDRX) United States $1.650B 30.71
Teladoc Health (TDOC) United States $1.337B 0.00
Pediatrix Medical (MD) United States $1.239B 9.42
Agilon Health (AGL) United States $1.118B 0.00
Establishment Labs Holdings (ESTA) $1.011B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.898B 14.03
AMN Healthcare Services Inc (AMN) United States $0.830B 7.77
Embecta (EMBC) United States $0.731B 4.92
Nutex Health (NUTX) United States $0.696B 10.59
QDM (QDMI) Hong Kong, SAR China $0.691B 0.00
InnovAge Holding (INNV) United States $0.535B 0.00
Enhabit (EHAB) United States $0.530B 43.62
Auna S.A (AUNA) Luxembourg $0.510B 13.51
Sonida Senior Living (SNDA) United States $0.510B 0.00
LifeMD (LFMD) United States $0.387B 0.00
SBC Medicals (SBC) United States $0.363B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.362B 0.00
Performant Healthcare (PHLT) United States $0.202B 0.00
Oncology Institute (TOI) United States $0.200B 0.00
Beauty Health (SKIN) United States $0.184B 0.00
DocGo (DCGO) United States $0.153B 25.00
Sera Prognostics (SERA) United States $0.089B 0.00
So-Young (SY) China $0.087B 0.00
Basel Medical Group (BMGL) Singapore $0.083B 0.00
OncoCyte (OCX) United States $0.079B 0.00
Ascend Wellness Holdings (AAWH) United States $0.071B 0.00
KindlyMD (KDLY) United States $0.062B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.058B 0.00
Biodesix (BDSX) United States $0.053B 0.00
Pheton Holdings (PTHL) China $0.037B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
ModivCare (MODV) United States $0.017B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.012B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00